Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design
The field of targeted protein degradation, through the control of the ubiquitin–proteasome system (UPS), is progressing considerably; to exploit this new therapeutic modality, the proteolysis targeting chimera (PROTAC) technology was born. The opportunity to use PROTACs engaging of new E3 ligases th...
Main Authors: | Tommaso Palomba, Giusy Tassone, Carmine Vacca, Matteo Bartalucci, Aurora Valeri, Cecilia Pozzi, Simon Cross, Lydia Siragusa, Jenny Desantis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/22/14218 |
Similar Items
-
Microtubular TRIM36 E3 Ubiquitin Ligase in Embryonic Development and Spermatogenesis
by: Martina Mascaro, et al.
Published: (2022-01-01) -
Rise of TRIM8: A Molecule of Duality
by: Utsa Bhaduri, et al.
Published: (2020-12-01) -
TRIMming down Mycobacterium tuberculosis replication: TRIM32 is required for bacterial ubiquitination and autophagy induction in macrophages
by: Alessandra Romagnoli, et al.
Published: (2023-12-01) -
Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
by: Apirat Chaikuad, et al.
Published: (2022-11-01) -
TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases
by: Lorena Kumarasinghe, et al.
Published: (2021-04-01)